LT-β activators are a specialized group of chemical entities that target and modulate the activity of the protein lymphotoxin-beta (LT-β), which is part of the tumor necrosis factor (TNF) superfamily and plays a role in the organization of lymphoid tissue, the development of secondary lymphoid organs, and the regulation of immune responses. LT-β forms a heterotrimeric complex with lymphotoxin-alpha (LT-α) to interact with the LT-β receptor (LTβR), triggering a cascade of intracellular events that can influence inflammation and immune system architecture. The mechanisms through which LT-β activators function can manifest in several ways: direct activators may bind to LT-β itself, inducing a conformational change that enhances its affinity or efficacy in interacting with LTβR. This could amplify the downstream signaling pathways that are normally engaged upon LT-β/LTβR interaction.
Indirect activators may influence the expression levels of LT-β or LTβR, modulate the processing or maturation of these proteins, or alter the signaling environment in a manner that affects their interaction or the downstream signaling cascade. The study of LT-β activators is mainly focused on delineating the complex signaling pathways and understanding the role of LT-β in the immune system, which is of significant interest in the field of immunology research. By probing the function and regulation of LT-β through chemical activators, researchers can gain deeper insights into how immune responses and lymphoid tissue development are orchestrated at the molecular level.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, enhancing intracellular cyclic AMP levels. cAMP can activate protein kinase A, which can phosphorylate and activate LT-β, leading to increased activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of PDE, which enhances cAMP and cGMP levels. This could activate LT-β through the protein kinase A pathway. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP activates PKA and may thereby increase LT-β activity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside stimulates guanylate cyclase, promoting cGMP production. This can activate LT-β through the protein kinase G pathway. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
Sp-cAMPS is a cell-permeable cAMP analog that activates PKA, potentially increasing LT-β activity. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
As a cell-permeable cGMP analog, 8-Br-cGMP can activate protein kinase G, potentially enhancing LT-β activity. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits PDE3, leading to increased levels of cAMP, which can activate PKA and potentially enhance LT-β activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of PDE4, increasing cAMP levels, which could activate PKA and enhance LT-β activity. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a PDE3 inhibitor that increases cAMP levels, potentially activating PKA and enhancing LT-β activity. | ||||||